MORGAN NELSON: Open Payments
NPI 1093106510 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 93 payments from 16 companies in 2025. Trend: 2023 $919 · 2024 $1,651 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $453 |
| ABBVIE INC. | 24 | $379 |
| Janssen Biotech, Inc. | 14 | $189 |
| Phathom Pharmaceuticals, Inc. | 12 | $145 |
| PFIZER INC. | 4 | $84 |
| Madrigal Pharmaceuticals | 2 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Lilly USA, LLC | 3 | $64 |
| Biocon Biologics Inc | 3 | $59 |
| GENZYME CORPORATION | 2 | $58 |
Products named: ENTYVIO, RINVOQ, TREMFYA, VOQUEZNA, DUPIXENT, SKYRIZI, GATTEX, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
